AR062167A1 - Sistema de administracion gastrorretentivo - Google Patents
Sistema de administracion gastrorretentivoInfo
- Publication number
- AR062167A1 AR062167A1 ARP070103384A ARP070103384A AR062167A1 AR 062167 A1 AR062167 A1 AR 062167A1 AR P070103384 A ARP070103384 A AR P070103384A AR P070103384 A ARP070103384 A AR P070103384A AR 062167 A1 AR062167 A1 AR 062167A1
- Authority
- AR
- Argentina
- Prior art keywords
- tablet
- administration system
- gastrorretentive
- patient
- length
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Abstract
Composicion farmacéutica para la fabricacion de un sistema de administracion de fármacos gastrorretentivo que comprende una formulacion farmacéutica y una condicion de aplicacion de ésta. Reivindicacion 1: Un comprimido que comprende al menos un ingrediente activo, que se caracteriza porque el menos la longitud del comprimido en el estado anterior a la aplicacion es al menos 7/12, más preferiblemente al menos 8/12, más preferiblemente al menos 9/12, más preferiblemente al menos 10/12, más preferiblemente al menos 11/12, más preferiblemente al menos 12/12, más preferiblemente al menos 13/12, más preferiblemente al menos 14/12, más preferiblemente al menos 15/12, más preferiblemente 15/12, más preferiblemente al menos 16/12, más preferiblemente al menos 17/12, más preferiblemente al menos 18/12, más preferiblemente al menos 19/12, y más preferiblemente al menos 20/12 del diámetro pilorico del paciente, y después de ingerirlo en estado alimentado, la longitud del comprimido crece en el estomago hasta al menos 11/12, más preferiblemente al menos 12/12, más preferiblemente al menos 13/12, más preferiblemente al menos 14/12, y más preferiblemente al menos 15/12 del diámetro pilorico del paciente.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06118268A EP1886665A1 (en) | 2006-08-01 | 2006-08-01 | Gastro retentive delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR062167A1 true AR062167A1 (es) | 2008-10-22 |
Family
ID=37772838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070103384A AR062167A1 (es) | 2006-08-01 | 2007-08-01 | Sistema de administracion gastrorretentivo |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080031945A1 (es) |
| EP (2) | EP1886665A1 (es) |
| JP (1) | JP2009545557A (es) |
| AR (1) | AR062167A1 (es) |
| CA (1) | CA2657392A1 (es) |
| TW (1) | TW200817050A (es) |
| WO (1) | WO2008015162A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8679533B2 (en) * | 2002-07-25 | 2014-03-25 | Pharmacia Corporation | Pramipexole once-daily dosage form |
| US20050226926A1 (en) | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
| KR20070050081A (ko) | 2004-08-13 | 2007-05-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도 |
| KR101052436B1 (ko) * | 2004-08-13 | 2011-07-29 | 베링거 인겔하임 인터내셔날 게엠베하 | 프라미펙솔 또는 약제학적으로 허용되는 이의 염을함유하는 연장 방출형 정제 제형, 이의 제조방법 및 이의용도 |
| WO2007090883A1 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Extended release formulation |
| WO2007090881A2 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Modified release formulation |
| IL219169A0 (en) * | 2012-04-15 | 2012-07-31 | Yehuda Darshan | Apparatus for cleaning tissues from root canal by spinning liquid jet |
| CN106573015B (zh) | 2014-06-11 | 2021-11-26 | 麻省理工学院 | 肠溶弹性体 |
| US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
| WO2016057517A1 (en) * | 2014-10-07 | 2016-04-14 | Therakine | Micronized delivery material, method for manufacturing thereof and methods for application |
| MA40990A (fr) * | 2014-11-19 | 2017-09-26 | Biogen Ma Inc | Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle |
| EP3364946A4 (en) | 2015-10-23 | 2019-06-26 | Lyndra, Inc. | STOMACH DISTRIBUTION SYSTEMS FOR DELAYED RELEASE OF THERAPEUTIC ACTIVE SUBSTANCES AND METHOD FOR THEIR USE |
| WO2018064630A1 (en) | 2016-09-30 | 2018-04-05 | Lyndra, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
| JP2024510761A (ja) * | 2021-03-17 | 2024-03-11 | 上海雲晟研新生物科技有限公司 | ラコサミド医薬組成物、その製造方法及び応用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
| CH649215A5 (de) * | 1981-04-29 | 1985-05-15 | Hoffmann La Roche | Pharmazeutische praeparate. |
| US4424235A (en) * | 1981-09-14 | 1984-01-03 | Hoffmann-La Roche Inc. | Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor |
| GB9812426D0 (en) * | 1998-06-10 | 1998-08-05 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
| AP2002002410A0 (en) * | 1999-08-04 | 2002-03-31 | Ranbaxy Laboratories Ltd | Hydrodynamically Balancing Oral Drug Delivery System |
-
2006
- 2006-08-01 EP EP06118268A patent/EP1886665A1/en not_active Withdrawn
-
2007
- 2007-07-27 JP JP2009522233A patent/JP2009545557A/ja active Pending
- 2007-07-27 CA CA002657392A patent/CA2657392A1/en not_active Abandoned
- 2007-07-27 EP EP07787955A patent/EP2049078A1/en not_active Withdrawn
- 2007-07-27 WO PCT/EP2007/057738 patent/WO2008015162A1/en active Application Filing
- 2007-07-31 TW TW096128043A patent/TW200817050A/zh unknown
- 2007-08-01 US US11/832,048 patent/US20080031945A1/en not_active Abandoned
- 2007-08-01 AR ARP070103384A patent/AR062167A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1886665A1 (en) | 2008-02-13 |
| TW200817050A (en) | 2008-04-16 |
| CA2657392A1 (en) | 2008-02-07 |
| WO2008015162A1 (en) | 2008-02-07 |
| US20080031945A1 (en) | 2008-02-07 |
| JP2009545557A (ja) | 2009-12-24 |
| EP2049078A1 (en) | 2009-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR062167A1 (es) | Sistema de administracion gastrorretentivo | |
| AR039744A1 (es) | Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada | |
| GT200600445A (es) | Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo. | |
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| WO2008027854A3 (en) | Pharmaceutical compositions comprising hgh for oral delivery | |
| WO2008079404A3 (en) | Pharmaceutical compositions for treatment of parkinson's disease and related disorders | |
| HRP20121072T1 (hr) | Postupci za davanje tetrahidrobiopterina, povezani pripravci i postupci mjerenja | |
| BR0213175A (pt) | Forma galênica oral macroparticular para a liberação retardada e controlada de princìpios ativos farmacêuticos | |
| NZ603579A (en) | Controlled release formulations | |
| AR062583A1 (es) | Sistema de suministro de farmaco oral gastro-retentivo de liberacion extendida para valsartan | |
| BR112012030641B8 (pt) | Usos e composições para terapia farmacêutica oral | |
| NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
| EA201170529A1 (ru) | Система доставки лекарственного препарата с замедленным высвобождением | |
| AR061790A1 (es) | Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento | |
| AR077284A1 (es) | Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica | |
| AR045783A1 (es) | Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| BRPI0607172A2 (pt) | método para a ministração de pelo menos uma substáncia farmaceuticamente ativa a um paciente, combinação de medicamentos e uso de pelo menos uma substáncia farmaceuticamente ativa para a fabricação de uma combinação de medicamentos | |
| AR048806A1 (es) | Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio | |
| AR066666A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante | |
| BRPI0510855A (pt) | medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis | |
| AR046146A1 (es) | Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso | |
| Murata et al. | Development of film dosage form containing allopurinol for prevention and treatment of oral mucositis | |
| RU2011113733A (ru) | Производные 1-амино-алкилциклогексана для лечения когнитивного нарушения при шуме в ушах | |
| RU2010154623A (ru) | Производные 1-аминоалкилциклогексана для лечения расстройств сна |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |